About Us

Since 2016, Weill Cornell Medicine (New York) and the Gustave Roussy Cancer Campus (Paris) have joined forces to organize an annual conference that provides a forum for education, discussion, and networking among investigators interested in developing safe and effective RT-IT combinations (ImmunoRad).

Contact Info

Email
christine.corinus

Phone
+33 (0) 1 42 11 53 22

  Gustave Roussy Cancer Campus,
Research Department
Pièce 65 - B2M

 

Select your language

Our Events Schedule Plan

  • 17Sept. 2025

    Microphone 13.25-13.30 pm - Opening

    Eric Deutsch, phD, MD
    Director of Gustave Roussy Radiation Oncology Department and INSERM UMR 1030
     

    Microphone 13.25-13.30 pm: OPENING

    Welcome and introduction

    PRIMER ON RADIATIONS, CANCER IMMUNOLOGY AND IMMUNOTHERAPY

    Microphone 13.30-15.30 Session I:

    Cancer immunology and Immunotherapy

    (Oliver Kepp)

    Microphone 13.30-14.00: Innate Immunity,
    TBD

    Microphone 14.00-14.30: Adaptive Immunity,
    TBD

    Microphone 14.30-15.00: Immune Metabolism, 
    Pr Guido Kroemer,
    Cordeliers Research Center, FR

    Microphone 15.00-15.30: Immunogenic cell death and autophagy, 
    Dr Lorenzo Galluzzi,
    Weill Cornell Medicine, USA

    15.30-16.00: Coffee break and exhibition


    Microphone 16.00-18.00 Session II:

    Radiation dose, modalities and resistance

     (François de Kermengy)

    Microphone 16.00-16.30: Charged particles radiotherapy, 
    Pr Marco Durrante,
    German Cancer Research Center, G

    Microphone 16.30-17.00:
    TBD

    Microphone 17.00-17.30: Next generation approaches in radiotherapy,
    Pr Amir Abdollahi,
    NCT Heidelberg, G

    Microphone 17.30-18.00: Fatty acid metabolism and radiation-induced anti-tumor immunity,
    Dr Claire Vanpouille-Box
    Weill Cornell Medicine, USA

    Microphone 18.00-20.00

    Cocktail poster session and exhibition

     
  • 18Sept. 2025

    MAIN PROGRAM

    Microphone 8.30-10.00 Session III:

    Myeloid cells

    (Paul Bergeron)

    Microphone 8.30-9.00: Sepsis-trained macrophages promote antitumoral tissue-resident T cells,
    Pr Antoine Roquilly,
    Nantes University, FR

    Microphone 9.00-9.30: TBD

    Microphone 9.30-10.00: Dendritic cells as shepherds of T cell immunity in cancer,
    Dr Mikael Pittet,
    University of Geneva, SW

    10.00-10.30 Coffee break and exhibition


    Microphone 10.30-12.30 Session IV:

    Immunosuppression

     (Michele Mondini)

    Microphone 10.30-11.00: Microenvironmental reorganization in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging,
    Pr Johanna Joyce,
    University of Lausanne, SW

    Microphone 11.00-11.30: Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer,
    Dr Fatima Mechta-Grigoriou,
    Institut Curie, FR

    Microphone 11.30-12.00: Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1,
    Dr Monica Olcina,
    University of Oxford, UK

    Microphone 12.00-12.30: Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites,
    Pr Ralph Weichselbaum,
    Chicago University, USA

    12.30-14.00 Lunch break and exhibition


    Microphone 14.00-16.00 Session V:

    DNA damage

    (Marco)

    Microphone 14.00-14.30: The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy,
    Pr Sandra Demaria,
    Weill Cornell Medicine, USA

    Microphone14.30-15.00: TBD 

    Microphone 15.00-15.30: T-cell receptor determinants of response to chemo-radiation in locally-advanced HPV16-driven malignancies,
    Pr Kevin Harrington,
    ICR, UK 

    Microphone 15.30-16.00: Micronuclei induced by radiation, replication stress, or chromosome segregation errors do not activate cGAS-STING,
    Dr Crispin Hiley,
    UCL Cancer Institute

    16.00-16.30 coffee break and exhibition


    Microphone 16.30-18.00 Session VI:

    Next generation Immunotherapy

     (Marie Morfouace)

    Microphone 16.30-17.00: Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma,
    Dr Jerome Galon,
    Cordeliers Research Center, FR

    Microphone17.00-17.30: TBD

    Microphone 17.30-18.00: New immune-based approaches in the clinic,
    Pr Fabrice Barlesi,
    Gustave Roussy, FR 

    Microphone 20.00-00.00

    Gala dinner

  • 19Sept. 2025

    Microphone 8.30-10.0    Session VII:

    Tumor Microenvironment

     (Marine Fidelle/Carolina Alves Costa Silva)

    Microphone 8.30-9.00: Mechanisms regulating T-cell infiltration and activity in solid tumors,
    Pr George Coukos,
    CHUV, SW

    Microphone 9.00-9.30: Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease,
    Pr Martin Pruschy,
    University Hospital Zurich

    Microphone 9.30-10.00: Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1,
    Pr Tim Illidge,
    Manchester Cancer Research Center, UK

    10.00-10.30 Coffee break and exhibition

    Microphone 10.30-12.30 Session VIII:

    AI, Imaging and Radiomics

     (Ibrahim Bouakka)

    Microphone 10.30-11.00: First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET,
    Pr Idris Bahce,
    VUMC, NL

    Microphone 11.00-11.30: Translational frontiers and clinical opportunities of immunologically-fitted radiotherapy,
    Pr Eric Deutsch,
    Gustave Roussy, FR

    Microphone 11.30-12.00: TBD

    Microphone 12.00-12.30: Using AI tools for precision medicine and immunotherapy,
    Pr Fabrice André,
    Gustave Roussy, FR

    12.30-14.00 Lunch break and exhibition

    Microphone 14.00-16.00 Session IX:

    Adaptive Immunity

     (Pierre-Antoine Laurent)


    Microphone 14.00-14.30: Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality,
    Pr Laurence Zitvogel,
    Gustave Roussy, FR

    Microphone 14.30-15.00: TBD

    Microphone 15.00-15.30: Emerging evidence for adapting radiotherapy to immunotherapy,
    Pr Silvia Formenti,
    Weill Cornell Medicine, USA

    Microphone 15.30-16.00: TBD

    16.00-16.30 Coffee break and exhibition

    Microphone 16.30-18.00 Session X:

    Innate Immunity

     (Lydia Meziani)


    Microphone 16.30-17.00: Low-dose ionizing γ-radiation elicits the extrusion of neutrophil extracellular traps,
    Pr Ignacio Melero,
    Clinica Universidad de Navarra, S

    Microphone 17.00-17.30: TBD

    Microphone 17.30-18.00: TBD